Partner Antoinette Konski and Associate Simon Elliott authored, “Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis,” published in the May 14, 2013 edition of Genetic Engineering and Biotechnology News. The article provides a discussion of the U.S. patent landscape for induced pluripotent stem cells (iPSCs) and identifies key technologies and institutions that are leading research and development in the creation and use of iPSCs.
The article also was referenced in a May 14, 2013 piece in the Boston Business Journal, which discussed the growth in the number of iPSCs patents held by Cambridge-area companies.
Click here to read the entire article.
Author(s)
Related Insights
December 22, 2025
Labor & Employment Law Perspectives
‘Tis the Season
‘Tis the Season… You probably do not think of HR compliance when you hear the phrase. But the end of 2025 is a good time — even in the…
January 27, 2026
Events
Fashion Law 2025 Year in Review
In 2025, the fashion industry faced significant challenges and opportunities driven by geopolitical shifts, rising tariffs and trade policy changes, and evolving consumer expectations, while innovation in brand protection and strategic partnerships supported resilience and growth.
December 22, 2025
Foley Viewpoints
Guyana: A Primer on a Strategic U.S. Caribbean & South American Ally
Guyana does not currently have a binding corporate governance code, and minority shareholder protections are relatively weak. Foreign investors must therefore structure joint ventures and other partnerships carefully, using shareholder agreements, board representation rights, and dispute resolution clauses to safeguard their interests.